Repository logo
 

Tau aggregate imaging and transcriptomics of Alzheimer’s disease brain at different stages of disease

Accepted version
Peer-reviewed

Change log

Authors

Abstract

Tau aggregation plays a critical role in the development and progression of Alzheimer’s disease (AD). Tau aggregates of different sizes and shapes are formed which ultimately lead to the deposition of fibrillar tangles. We used single-molecule techniques to characterise tau aggregates in the middle temporal gyrus and somatosensory cortex in post-mortem brain homogenates at different Braak stages from patients with AD. Total and phosphorylated tau aggregates increased dramatically in late Braak stages. The aggregates showed greater multi-site phosphorylation with increased Braak stage but there was only a moderate change in the aggregate size distribution. Paired single nuclei transcriptomic analyses provided evidence for greater pro-inflammatory microglial and complement pathway activation with increasing phosphorylated tau aggregate concentration and length. Based on this correlation, we hypothesise a cascade of disease progression in which microglial inflammation induces tau aggregation in neighbouring neurons that, in turn, further enhances inflammation and the spread of tau pathology to increase the concentration of small tau aggregates.

Description

Keywords

Journal Title

Advanced Science

Conference Name

Journal ISSN

2198-3844
2198-3844

Volume Title

Publisher

Wiley

Publisher DOI

Publisher URL

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Royal Society (RSRP\R\210003)
We thank the donors and their families for the human brain tissue in this study and UK brain bank staff for making it available. Thanks to Dr Jeff YL Lam, for support with amyloid-beta fibril generation used as 6E10 Simoa calibrants, and DNA labelling AT8 and HT7 antibody for PAINT imaging. Tissue samples were provided by the London Neurodegenerative Diseases Brain Bank at King's College London, which receives funding from the UK Medical Research Council and from the Brains for Dementia Research programme, jointly funded by Alzheimer’s Research UK and the Alzheimer’s Society. Tissue samples and associated clinical and neuropathological data also were supplied by Parkinson's UK Brain Bank at Imperial, funded by Parkinson's UK, a charity registered in England and Wales (258197) and in Scotland (SC037554). We are grateful to Diana Benitez for her support with human tissue management on behalf of the UK DRI Multi-‘omics Atlas Project. Infrastructure, including particularly the LMS/NIHR Imperial Biomedical Research Centre Flow Cytometry Facility and the Imperial BRC Genomics Facility, was supported by the Imperial College Healthcare Trust National Institute for Health Research (NIHR) Biomedical Research Centre (BRC). PMM acknowledges generous personal support from the Edmond J Safra Foundation and Lily Safra and an NIHR Senior Investigator Award. NF is an Edmond and Lily Safra fellow funded by the Edmond J. Safra Foundation. D.K. is funded by the UK Dementia Research Institute (UK DRI Ltd.) and by the Medical Research Council UK and the Royal Society UK.